ResMed targets 59-60% gross margins and expanded global reach for AirSense 11
Q2 2025 Management View CEO Michael Farrell reported 10% global revenue growth, driven by demand across the sleep health, ...
The Financial Express24d
ResMed launches new device for patients of sleep apnea in India
There is a need to address the rising cases of sleep apnea in India. (Image Credits: Pixabay) ResMed on Tuesday announced that it has launched AirSense 11 in India. According to the company’s ...
fnarena2d
ResMed: Another Positive Quarterly Surprise?
UBS makes a similar comment, stating ResMed shares are trading at 23x FY26 earnings. Although this represents a 40% premium ...